Fructose-Derived Advanced Glycation End-Products Evoke Skeletal Muscle Damage in Mice by Multiple Interference with SCAP-SREBP Pathway

2014 ◽  
Vol 76 ◽  
pp. S101
Author(s):  
Raffaella Mastrocola ◽  
Debora Nigro ◽  
Fausto Chiazza ◽  
Massimo Collino ◽  
Manuela Aragno
PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0119587 ◽  
Author(s):  
Raffaella Mastrocola ◽  
Massimo Collino ◽  
Debora Nigro ◽  
Fausto Chiazza ◽  
Giuseppe D’Antona ◽  
...  

2020 ◽  
Vol 176 ◽  
pp. 332-340
Author(s):  
Tatsuro Egawa ◽  
Kohei Kido ◽  
Takumi Yokokawa ◽  
Mami Fujibayashi ◽  
Katsumasa Goto ◽  
...  

2008 ◽  
Vol 283 (52) ◽  
pp. 36088-36099 ◽  
Author(s):  
Angela Cassese ◽  
Iolanda Esposito ◽  
Francesca Fiory ◽  
Alessia P. M. Barbagallo ◽  
Flora Paturzo ◽  
...  

2021 ◽  
Vol 8 (11) ◽  
pp. 168
Author(s):  
Lucas C. Olson ◽  
James T. Redden ◽  
Zvi Schwartz ◽  
David J. Cohen ◽  
Michael J. McClure

Advanced age causes skeletal muscle to undergo deleterious changes including muscle atrophy, fast-to-slow muscle fiber transition, and an increase in collagenous material that culminates in the age-dependent muscle wasting disease known as sarcopenia. Advanced glycation end-products (AGEs) non-enzymatically accumulate on the muscular collagens in old age via the Maillard reaction, potentiating the accumulation of intramuscular collagen and stiffening the microenvironment through collagen cross-linking. This review contextualizes known aspects of skeletal muscle extracellular matrix (ECM) aging, especially the role of collagens and AGE cross-linking, and underpins the motor nerve’s role in this aging process. Specific directions for future research are also discussed, with the understudied role of AGEs in skeletal muscle aging highlighted. Despite more than a half century of research, the role that intramuscular collagen aggregation and cross-linking plays in sarcopenia is well accepted yet not well integrated with current knowledge of AGE’s effects on muscle physiology. Furthermore, the possible impact that motor nerve aging has on intramuscular cross-linking and muscular AGE levels is posited.


2021 ◽  
Vol 22 (16) ◽  
pp. 8832
Author(s):  
Lucas C. Olson ◽  
Tri M. Nguyen ◽  
Rebecca L. Heise ◽  
Barbara D. Boyan ◽  
Zvi Schwartz ◽  
...  

Decellularized tissues are biocompatible materials that engraft well, but the age of their source has not been explored for clinical translation. Advanced glycation end products (AGEs) are chemical cross-links that accrue on skeletal muscle collagen in old age, stiffening the matrix and increasing inflammation. Whether decellularized biomaterials derived from aged muscle would suffer from increased AGE collagen cross-links is unknown. We characterized gastrocnemii of 1-, 2-, and 20-month-old C57BL/6J mice before and after decellularization to determine age-dependent changes to collagen stiffness and AGE cross-linking. Total and soluble collagen was measured to assess if age-dependent increases in collagen and cross-linking persisted in decellularized muscle matrix (DMM). Stiffness of aged DMM was determined using atomic force microscopy. AGE levels and the effect of an AGE cross-link breaker, ALT-711, were tested in DMM samples. Our results show that age-dependent increases in collagen amount, cross-linking, and general stiffness were observed in DMM. Notably, we measured increased AGE-specific cross-links within old muscle, and observed that old DMM retained AGE cross-links using ALT-711 to reduce AGE levels. In conclusion, deleterious age-dependent modifications to collagen are present in DMM from old muscle, implying that age matters when sourcing skeletal muscle extracellular matrix as a biomaterial.


Sign in / Sign up

Export Citation Format

Share Document